Arcadia Biosciences, Inc.
RKDA
$3.59
$0.336910.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.06M | -1.61M | 1.06M | -2.42M | -2.85M |
| Total Depreciation and Amortization | 171.00K | 157.00K | 209.00K | 228.00K | 222.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.16M | -58.00K | -3.59M | -417.00K | -306.00K |
| Change in Net Operating Assets | -471.00K | -239.00K | -138.00K | -598.00K | -1.21M |
| Cash from Operations | -2.21M | -1.75M | -2.46M | -3.21M | -4.15M |
| Capital Expenditure | 0.00 | 0.00 | -3.00K | -13.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -8.00K | 180.00K | 145.00K | 17.00K | 73.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.52M | 0.00 | 4.50M | -- | -21.00K |
| Cash from Investing | 2.52M | 180.00K | 4.64M | 4.00K | 52.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 4.00K | 0.00 | 5.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 0.00 | 4.00K | 0.00 | 5.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 306.00K | -1.57M | 2.19M | -3.20M | -4.09M |